Along with the development of tumour, advanced tumours and metastases develop several ways to evade NKG2D signalling including repression of NKG2DL transcription and shedding of soluble MHC class I chain‐related molecule A (sMICA) 16, 27. Here, KLRK1 is linked to neoplasm.